New York Blood Center National Cord Blood Program

Stopped early · Early Phase 1

Conditions studied: Leukemia, Lymphoma, Genetic Disease, Severe Aplastic Anemia, Myelodysplasia

In brief

Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftment, transplant related mortality, overall survival, graft vs. host disease and, for patients with leukemia, lymphoma or myelodysplasia, relapse.

Key facts

Study ID

NCT00212407

Run by

New York Blood Center

People needed

4476

Starts

1993-02-01

Expected to finish

2011-11-10

Last updated by the study team

2018-11-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Candidates for bone marrow transplantation

Where it is running

• New York Blood Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.